Agonists of GLP-1 receptors have been shown to reduce anxiety-like behaviors in rodent models, possibly by maintaining BDNF and Nrf2 levels and reducing oxidative stress and lipocalin 2 in the hippocampus (Cawthon and de La Serre, 2018; Sağlam et al., 2022). Here, BDNF is linked to Anxiety.